A survey of knowledge and use of folic acid among women of child-bearing age in dublin

Journal of Public Health (United Kingdom)

Volumn 19, Issue 3, 1997, Pages 328-332

  Sayers, G M ^a   Hughes, N ^a   Scallan, E ^a   Johnson, Z ^a  

^a DR STEEVENS HOSPITAL   (Ireland)

Author keywords

folic acid; neural tube defects; prevention

Indexed keywords

FOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; DIET SUPPLEMENTATION; EDUCATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERVIEW; IRELAND; MEDICAL RESEARCH; NEURAL TUBE DEFECT; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL CLASS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IRELAND; NEURAL TUBE DEFECTS; PRECONCEPTION CARE; PREGNANCY; SOCIOECONOMIC FACTORS;

EID: 0030782251     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/oxfordjournals.pubmed.a024639     Document Type: Article

References (19)

1. Hibbard ED, Smithells RW. Folic acid metabolism and human embryopathy. Lancet 1965; 1: 1254-1256.
2. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural tube defects by periconceptional folic vitamin supplementation. Lancet 1980; 1: 339-340.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects. Results of the Medical Research Council vitamin study. Lancet 1991; 338: 131-137.
4. Czeizel AE, Dundas, I. Prevention of the first occurrence of neural tube defects by periconceptional folic acid. N Engl J Med 1992; 327: 1832-1835.
5. Kirke PN, Daly LE, Elwood JH. A randomised trial of low dose folic acid to prevent neural tube defects. Arch Dis Child 1992; 67: 1442-1446.
6. Department of Health. Folic acid and the prevention of neural tube defects. Report from an Expert Advisory Group. Heywood: Department of Health Publications Unit, 1992.
7. Moss AJ, Levy AS, Kim I, et al. Use of vitamin and mineral supplements in the US. Current users, types ofproducts and nutrients. Hyattsville, MD: US Department of Health and Human Service, Public Health Service, CDC, NCHS, 1989.
8. Anonymous. What every woman needs to know about the prevention of neural tube defects, spina bifida, anencephaly. Dublin: Health Promotion Unit, 1993.
9. Clark NLA, Fisk NM. Minimal compliance with the Department of Health recommendations for routine folate prophylaxis to prevent fetal neural defects. Br J Obstet Gynaecol 1994; 101: 709-710.
10. Doyle W. Prevention of neural tube defects (letter). Lancet 1995; 1: 389-390.
11. Sutcliff M, Schorah CJ, Perry A, Wild J. Prevention of neural tube defects. Lancet 1993; 342: 1174.
12. Sutcliff M, Schorah CJ, Perry A, Wild J. Prevention of neural tube defects. Lancet 1994; 344: 1578.
13. EUROCAT. Surveillance of congenital anomalies in Europe 1980-92-Report 6. Brussels: Institute of Hygiene and Epidemiology, 1995.
14. Milner M, Slevin J, Morrow A, et al. Suboptimal compliance with periconceptional folic acid in an Irish hospital population. Irish Med J 19%; 89(1): 28-29.
15. O'Hare A, Whelan CT, Cummins P. The development of an Irish census-based social class scale. Econ Social Rev 1991; 20: 135-156.
16. Johnson RB, Staples DA. Knowledge and use of folic acid by women of childbearing age in US 1995. MMWR 1995; 48(38): 716-717.
17. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995; 274(21): 1698-1718.
18. Wald NJ, Bonar C. Folic acid and the prevention of neural tube defects. Br Med J 1995; 310: 1019-1020.
19. Romano PS, Waitzman NJ, Scheffer RM, Pi RD. Folic acid fortification of grain. An economic analysis. Am J Publ Hlth 1995; 85: 667-673.